Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
Yokoyama Y, Matsuoka K, Kobayashi T, Sawada K, Fujiyoshi T, Ando T, Ohnishi Y, Ishida T, Oka M, Yamada M, Nakamura T, Ino T, Numata T, Aoki H, Sakou J, Kusada M, Maekawa T, Hibi T. Yokoyama Y, et al. Among authors: oka m. J Crohns Colitis. 2014 Sep;8(9):981-91. doi: 10.1016/j.crohns.2014.01.027. Epub 2014 Feb 18. J Crohns Colitis. 2014. PMID: 24556083 Clinical Trial.
The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis).
Mohri M, Gonda Y, Oka M, Aoki Y, Gomi K, Kiyota T, Sugihara T, Yamamoto S, Ishida T, Maruyama I. Mohri M, et al. Among authors: oka m. Blood Coagul Fibrinolysis. 1997 Jul;8(5):274-83. doi: 10.1097/00001721-199707000-00003. Blood Coagul Fibrinolysis. 1997. PMID: 9282791
Successful treatment with bortezomib for refractory cryoglobulinemic vasculitis triggered by ischemic non-obstructive coronary artery disease.
Ohta Y, Tsuchiya T, Oka M, Tachibana M, Kondo Y, Fukushima K, Matsuno S, Yamanaka N, Suzuki N, Komatsu A, Rokutan H, Yumura W, Arai T, Ishigami A, Itabashi M, Takei T. Ohta Y, et al. Among authors: oka m. CEN Case Rep. 2025 Jan 6. doi: 10.1007/s13730-024-00963-2. Online ahead of print. CEN Case Rep. 2025. PMID: 39760978 Free article.
Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial.
Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Ohtake T, et al. Among authors: oka m. World J Stem Cells. 2024 Dec 26;16(12):1012-1021. doi: 10.4252/wjsc.v16.i12.1012. World J Stem Cells. 2024. PMID: 39734483 Free PMC article. Clinical Trial.
2,313 results